Fubotv earnings beat by $0.10, revenue topped estimates
Jamie L. Reynoso, CEO, Medicare Advantage at Clover Health Investments, CORP. /DE (NASDAQ:CLOV), sold 6,823 shares of Class A Common Stock on August 4, 2025, for a total of $19,718. The healthcare company, with a market capitalization of $1.15 billion, has seen its stock decline 47.7% over the past six months according to InvestingPro data.
The shares were sold at a weighted average price of $2.89, in multiple transactions at prices ranging from $2.86 to $2.93. This sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2025. Following the transaction, Reynoso directly owns 3,261,485 shares of Clover Health Investments, CORP. /DE. The stock currently trades at $2.26, below InvestingPro’s Fair Value estimate, suggesting potential upside. While management has been actively buying back shares, investors can access detailed insider trading patterns and 11 additional ProTips through the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Clover Health Investments Corp reported its second-quarter 2025 earnings, revealing a revenue of $477.62 million. This figure surpassed analysts’ expectations of $468.3 million, resulting in a 1.99% revenue surprise. Despite the positive revenue results, the stock experienced a slight dip post-announcement. These developments come amid a backdrop of investor scrutiny and market fluctuations. Analyst firms have been closely monitoring Clover Health’s performance, though no specific upgrades or downgrades were noted in the recent reports. The company’s financial results continue to draw attention from the investment community. Clover Health’s revenue performance is a focal point for stakeholders assessing the company’s financial health. Recent developments highlight the importance of earnings and revenue figures in shaping investor sentiment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.